#brain_cancer

Ángel Álvarez-Prado

@alvarezprado.bsky.social

5 days ago

🚨We’re hiring a postdoc! If you’re interested in #ageing #immunology #genomics and #brain_cancer, please apply in the link below!

🔬 We study the impact of ageing and genetic variation on the immune microenvironment and therapy responses.

📅 Deadline: 30th April 2026.

www.lih.lu/en/job/?valu...

Thiard News@F4F

@newsen.bsky.social

3 weeks ago

Innovative Study Launching Mild Hyperbaric Oxygen Therapy for Brain Cancer Treatment Australian researchers at Southern Cross University are pioneering a clinical study on the impacts of mild hyperbaric oxygen therapy for brain cancer patients during active treatment.

Innovative Study Launching Mild Hyperbaric Oxygen Therapy for Brain Cancer Treatment #Australia #Hyperbaric_Therapy #brain_cancer #Lismore #Southern_Cross_University

Ángel Álvarez-Prado

@alvarezprado.bsky.social

7 months ago

Cancer cell and microenvironmental rewiring by ADAR1 loss impairs glioblastoma tumor growth and extends survival Álvarez-Prado et al. report that targeting ADAR1 triggers cancer-cell-intrinsic anti-proliferative mechanisms and fosters anti-tumoral immune responses, blocking tumor growth and extending survival in...

Can we exploit anti-viral immunity to treat brain cancer? 🦠 🧠

Our last results suggest so, go ahead and check the paper if you’re curious! 🤓

www.cell.com/cell-reports...

#Brain_cancer #Glioblastoma #TumorMicroenvironment #RNAsensing #ADAR1

Thiard News@F4F

@newsen.bsky.social

7 months ago

Curasight's uTREAT® Approved for Phase 1 Trial in Brain Cancer Treatment Curasight A/S has received approval for a Phase 1 clinical trial of uTREAT® targeting aggressive brain cancers, marking a major advancement in treatment options.

Curasight's uTREAT® Approved for Phase 1 Trial in Brain Cancer Treatment #Denmark #Copenhagen #Curasight #brain_cancer #uTREAT

Thiard News@F4F

@newsen.bsky.social

7 months ago

Curasight's uTREAT® Approved for Phase 1 Trial in Brain Cancer Patients Curasight has received approval for the Phase 1 clinical trial of its innovative uTREAT® therapy aimed at treating aggressive brain cancers, promising targeted treatment options for patients.

Curasight's uTREAT® Approved for Phase 1 Trial in Brain Cancer Patients #Denmark #Copenhagen #Curasight #uTREAT® #brain_cancer

@cornelius1ste.bsky.social

10 months ago

"Now, research out of Emory University and QIMR Berghofer Medical Research Institute shows that a potential new targeted therapy for childhood brain cancer is effective in infiltrating and killing tumor cells in preclinical models tested in mice." #brain_cancer #cancer

lnkd.in/epPexFyb

Ángel Álvarez-Prado

@alvarezprado.bsky.social

1 year ago

Extraordinary resource for the #brain_cancer community from @johannajoyce.bsky.social lab, led by the equally extraordinary @lbejarano.bsky.social, so happy to see this out! 👏 👏 👏

Norbert_R 🦣 🐋🐘

@norbert-renner.mastodon.social.ap.brid.gy

1 year ago

#SGU #TheSkepticsGuideToTheUniverse:
The Skeptics Guide #1008 - Nov 2 2024

Quickie with Bob: Predicting #Earthquakes; News Items: #Cell_Phones and #Brain_Cancer, #Gold from Earthquakes, #Plastic in the #Brain, #Quantum #Neural_Network, #Marmosets have Names; Your questions and E-mails […]